Aspiriant LLC’s WisdomTree Emerging Markets High Dividend Fund DEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4M | Sell |
360,842
-24,298
| -6% | -$1.3M | 0.48% | 32 |
|
|
2026
Q1 | $19.1M | Sell |
385,140
-27,286
| -7% | -$1.35M | 0.55% | 31 |
|
|
2025
Q4 | $19.3M | Sell |
412,426
-7,554
| -2% | -$350K | 0.55% | 31 |
|
|
2025
Q3 | $19.3M | Sell |
419,980
-2,495
| -0.6% | -$115K | 0.59% | 27 |
|
|
2025
Q2 | $19.1M | Sell |
422,475
-17,287
| -4% | -$744K | 0.61% | 28 |
|
|
2025
Q1 | $18.5M | Sell |
439,762
-12,040
| -3% | -$502K | 0.64% | 23 |
|
|
2024
Q4 | $18.3M | Sell |
451,802
-14,502
| -3% | -$613K | 0.66% | 24 |
|
|
2024
Q3 | $20.5M | Sell |
466,304
-23,499
| -5% | -$1.02M | 0.78% | 20 |
|
|
2024
Q2 | $21.2M | Sell |
489,803
-22,540
| -4% | -$969K | 0.86% | 19 |
|
|
2024
Q1 | $21.4M | Sell |
512,343
-43,620
| -8% | -$1.78M | 0.89% | 18 |
|
|
2023
Q4 | $22.6M | Sell |
555,963
-43,803
| -7% | -$1.68M | 1.02% | 18 |
|
|
2023
Q3 | $22.5M | Sell |
599,766
-12,184
| -2% | -$474K | 1.15% | 18 |
|
|
2023
Q2 | $23.4M | Sell |
611,950
-19,823
| -3% | -$762K | 1.18% | 18 |
|
|
2023
Q1 | $23.9M | Sell |
631,773
-9,178
| -1% | -$346K | 1.25% | 14 |
|
|
2022
Q4 | $22.8M | Sell |
640,951
-219,076
| -25% | -$7.6M | 1.16% | 17 |
|
|
2022
Q3 | $28M | Sell |
860,027
-156,069
| -15% | -$5.65M | 1.37% | 18 |
|
|
2022
Q2 | $37.6M | Buy |
1,016,096
+53,814
| +6% | +$2.19M | 1.82% | 13 |
|
|
2022
Q1 | $42.1M | Sell |
962,282
-21,814
| -2% | -$969K | 2.32% | 12 |
|
|
2021
Q4 | $42.6M | Sell |
984,096
-12,782
| -1% | -$557K | 2.28% | 12 |
|
|
2021
Q3 | $43.5M | Sell |
996,878
-1,469
| -0.1% | -$65.9K | 2.55% | 12 |
|
|
2021
Q2 | $45.6M | Buy |
998,347
+43,245
| +5% | +$1.98M | 2.58% | 10 |
|
|
2021
Q1 | $42.4M | Sell |
955,102
-8,316
| -0.9% | -$358K | 2.71% | 11 |
|
|
2020
Q4 | $39.6M | Sell |
963,418
-24,403
| -2% | -$935K | 2.7% | 12 |
|
|
2020
Q3 | $34.8M | Sell |
987,821
-112,602
| -10% | -$4.22M | 2.72% | 12 |
|
|
2020
Q2 | $39.8M | Sell |
1,100,423
-1,211,084
| -52% | -$42.7M | 3.69% | 10 |
|
|
2020
Q1 | $74.6M | Buy |
2,311,507
+2,044,855
| +767% | +$82.8M | 7.34% | 2 |
|
|
2019
Q4 | $12.2M | Buy |
266,652
+2,527
| +1% | +$110K | 1.13% | 21 |
|
|
2019
Q3 | $10.9M | Buy |
264,125
+2,664
| +1% | +$114K | 0.98% | 23 |
|
|
2019
Q2 | $11.7M | Sell |
261,461
-37,076
| -12% | -$1.62M | 0.97% | 22 |
|
|
2019
Q1 | $13.1M | Sell |
298,537
-313,140
| -51% | -$13.5M | 1.07% | 21 |
|
|
2018
Q4 | $24.6M | Buy |
611,677
+559,956
| +1,083% | +$23M | 1.86% | 16 |
|
|
2018
Q3 | $2.26M | Buy |
51,721
+44,250
| +592% | +$1.93M | 0.19% | 76 |
|
|
2018
Q2 | $320K | Sell |
7,471
-250
| -3% | -$11.4K | 0.03% | 196 |
|
|
2018
Q1 | $369K | Buy |
+7,721
| New | +$369K | 0.03% | 170 |
|
Other funds holding DEM
KIM
Aspiriant LLC's DEM Position: Q2 2026 in Review
Aspiriant LLC reduced its WisdomTree Emerging Markets High Dividend Fund (DEM) stake by 6.3% in Q2 2026, selling an estimated $1.3M and leaving 360,842 shares worth $19.4M. The position accounts for 0.48% of the portfolio, ranked #32.
Aspiriant LLC first reported a position in DEM in Q1 2018 and has held it in 34 quarters since. The position peaked at $74.6M in Q1 2020. 369 funds tracked by Wall St. Rank hold DEM as of Q2 2026.
- Aspiriant LLC held 360,842 shares of WisdomTree Emerging Markets High Dividend Fund worth $19.4M as of Q2 2026.
- Aspiriant LLC sold 24,298 WisdomTree Emerging Markets High Dividend Fund shares in Q2 2026, an estimated $1.3M.
- WisdomTree Emerging Markets High Dividend Fund made up 0.48% of Aspiriant LLC's portfolio in Q2 2026, its #32 holding.
- Aspiriant LLC first reported a position in WisdomTree Emerging Markets High Dividend Fund in Q1 2018 and has held it in 34 quarters since.
- Aspiriant LLC's WisdomTree Emerging Markets High Dividend Fund position peaked at $74.6M in Q1 2020.
- 369 funds tracked by Wall St. Rank held WisdomTree Emerging Markets High Dividend Fund as of Q2 2026.
Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.